PureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

Sept. 14, 2021 11:00 UTC

 

 
 

BOSTON--(BUSINESS WIRE)-- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that George Farmer, Ph.D., Chief Financial Officer, will present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit on September 21, 2021 at 4:35 PM EDT. A webcast of the presentation will be available at https://investors.puretechhealth.com/events-presentations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210914005224/en/

PureTech's Chief Financial Officer, George Farmer, Ph.D., will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 21 at 4:35pm EDT. (Photo: Business Wire)

PureTech's Chief Financial Officer, George Farmer, Ph.D., will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 21 at 4:35pm EDT. (Photo: Business Wire)

About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 25 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization, as of the date of PureTech's most recently filed Half Year Report and corresponding Form 6-K. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on the Company's unique insights into the biology of the brain, immune and gut, or BIG, systems and the interface between those systems, referred to as the BIG Axis.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh

Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments, and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, our expectations regarding the potential therapeutic benefits of our therapeutic candidates and those risks and uncertainties described in the risk factors included in the regulatory filings for PureTech Health plc. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law and regulatory requirements, neither the company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. 

Contacts

Investors
Allison Mead Talbot
+1 617 651 3156
amt@puretechhealth.com

U.S. media
Nichole Sarkis
+1 774 278 8273
nichole@tenbridgecommunications.com

 
 

Source: PureTech Health plc

Smart Multimedia Gallery

PureTech's Chief Financial Officer, George Farmer, Ph.D., will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 21 at 4:35pm EDT. (Photo: Business Wire)

View this news release and multimedia online at:
http://www.businesswire.com/news/home/20210914005224/en

Back to news